Keywords: Bayer, Eylea, Regeneron, Wet-AMD, Abbott Labs, Humira, Pediatric Crohn's, European Commission

EU Commission approves Bayer's Eylea for wet AMD and Abbott's Humira for pediatric Crohn's

Article | 28 November 2012

Print This

There was good news yesterday for Germany’s Bayer (BAYN: DE) and US health care major Abbott Laboratories (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in